首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1593524

細胞分離市場規模、佔有率和成長分析（按產品、按細胞類型、按細胞來源、按技術、按應用、按地區）：產業預測（2024-2031）

Cell Isolation Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells), By Cell Source, By Technique, By Application, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月09日 | 出版商:

SkyQuest | 英文 188 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球細胞分離市場規模估值為42億美元，從2023年的47.4億美元成長到2031年的124.2億美元，在預測期間（2024-2031）預計複合年成長率為12.80%。

全球細胞分離市場由於其在生技藥品開發、治療性蛋白質合成、內部分析和研究等應用中的重要作用而正在經歷強勁成長。癌症和 COVID-19 等慢性疾病的盛行率上升和成本上升，加上政府加強生物技術的舉措，是關鍵的成長決定因素。 NanoString Technologies、Levitas Bio 和 Bionano Genomics 等公司正在改進其製造流程並擴大其產品範圍，以便為高級應用領域實現精確的細胞選擇。 COVID-19 大流行進一步加速了新療法和診斷輔助手段的研究，2020 年 8 月美國緊急支出法案等舉措正在推動對細胞分離設備的需求。隨著專科藥物和學名藥呈指數級成長，對生物製藥的依賴日益增加將推動市場的發展。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 波灣合作理事會(GCC) 國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

丹納赫公司（美國）
默克公司（德國）
賽默飛世爾科技公司（美國）
BD（貝克頓迪金森公司）（美國）
賽多利斯股份公司（德國）
安捷倫科技公司（美國）
Bio-Rad 實驗室公司（美國）
凱傑（荷蘭）
F. Hoffmann-La Roche Ltd.（瑞士）
復興（美國）
龍沙（瑞士）
Bio-Techne（美國）
泰爾茂株式會社（日本）
Miltenyi Biotec（德國）
Takara Bio Inc.（日本）
金斯瑞（中國）
標準生物工具（美國）
Alfa Laval (Sweden)
Promega 公司（美國）
Cell Signaling Technology, Inc.（美國）
米卡雷奧公司（美國）
應用細胞公司（美國）
幹細胞技術（加拿大）
創意生物陣列（美國）
Proteintech Group, Inc.（美國）
Magbio Genomics, Inc.（美國）
生命科學學院（美國）
Pluriselect Life Science Ug (Haftungsbeschrankt) & Co. KG（德國）
發明生物技術公司（美國）

簡介目錄

Product Code: SQMIG35H2298

Global Cell Isolation Market size was valued at USD 4.2 billion in 2022 and is poised to grow from USD 4.74 billion in 2023 to USD 12.42 billion by 2031, growing at a CAGR of 12.80% during the forecast period (2024-2031).

The global cell isolation market is witnessing robust growth driven by its critical role in applications such as biologics development, therapeutic protein synthesis, internal analysis, and research. Rising prevalence and costs of chronic diseases like cancer and COVID-19, coupled with government initiatives to bolster biotechnology, are key growth determinants. Companies like NanoString Technologies, Levitas Bio, and Bionano Genomics are enhancing their manufacturing processes and expanding product offerings, enabling precise cell selection for advanced applications. The COVID-19 pandemic further accelerated research in new treatment and diagnostic aids, with initiatives like the U.S. emergency spending bill of August 2020 boosting demand for cell isolation equipment. Growing reliance on biopharmaceuticals fuels the market as specialty and generic medicines expand exponentially.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Isolation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Isolation Market Segmental Analysis

Global Cell Isolation Market is segmented by Product, Cell Type, Cell Source, Technique, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Cell Type, the market is segmented into Human Cells, and Animal Cells. Based on Cell Source, the market is segmented into Adipose Tissue, Bone Marrow, Cord Blood/Embryonic Stem Cells, and Other Cell Sources. Based on Technique, the market is segmented into Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, and Filtration-Based Cell Isolation. Based on Application, the market is segmented into Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue, Regeneration & Regenerative Medicine, In Vitro Diagnostics, and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Isolation Market

One of the key drivers of the global cell isolation market is the rising prevalence of chronic diseases, particularly cancer. As cancer cases surge globally, there is a growing demand for advanced research and treatment solutions. Cell isolation plays a pivotal role in cancer research by enabling the study of specific cell types, facilitating the development of targeted therapies and personalized medicine. Isolated cells provide critical insights into tumor biology, drug resistance, and immune responses, driving the creation of more effective treatments. Additionally, the increasing adoption of advanced therapies, such as immunotherapy, further boosts the demand for cell isolation techniques. This trend underscores the importance of innovation in the cell isolation market, as research institutes and biotech firms intensify their efforts to combat chronic diseases.

Restraints in the Global Cell Isolation Market

A significant restraint in the global cell isolation market is the high cost of specialized equipment and technologies required for isolating specific cell types. Advanced tools such as flow cytometers, centrifuges, and magnetic-activated cell sorting (MACS) systems are costly, limiting access, particularly for smaller research institutions and laboratories. Additionally, the ongoing expenses related to reagents, as well as the need for highly skilled personnel to operate the equipment, further elevate the financial burden. These factors may restrict the widespread adoption and utilization of advanced cell isolation techniques, particularly in regions with limited financial resources or budget constraints.

Market Trends of the Global Cell Isolation Market

A key trend shaping the global cell isolation market is the growing adoption of microfluidics technology. This innovative approach utilizes small quantities of fluids through microchannels to precisely separate cells based on characteristics such as length, shape, and other biological properties. Microfluidics is gaining significant traction for its ability to efficiently isolate rare cells, such as circulating tumor cells (CTCs) and stem cells, from complex biological samples. Its enhanced precision and performance, coupled with cost-effective processing that minimizes reagent usage, make it a highly attractive solution for both research and medical applications. As a result, microfluidics is poised to revolutionize cell isolation, offering improved accuracy and efficiency in diverse clinical and research settings.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Technology Analysis
Pricing Analysis
Value Chain Analysis
Patent Analysis
Supply Chain Analysis
Regulatory Landscape
Customer & Buying Criteria Analysis

Cell Isolation Market by Product

Market Overview
Consumables
- Reagents, Kits, Media, And Sera
- Beads
- Magnetic Beads
- Fluorescent Beads
- Disposables
Instruments
- Centrifuges
- Cell Sorters
- Magnetic-Activated Cell Separator Systems
- Filtration Systems

Cell Isolation Market by Cell Type

Market Overview
Human Cells
- Differentiated Cells
- Stem Cells
Animal Cells

Cell Isolation Market by Cell Source

Market Overview
Adipose Tissue
Bone Marrow
Cord Blood/Embryonic Stem Cells
Other Cell Sources

Cell Isolation Market by Technique

Market Overview
Centrifugation-Based Cell Isolation
Surface Marker-Based Cell Isolation
Filtration-Based Cell Isolation

Cell Isolation Market by Application

Market Overview
Biomolecule Isolation
Cancer Research
Stem Cell Research
Tissue Regeneration & Regenerative Medicine
In Vitro Diagnostics
Other Applications

Cell Isolation Market by End User

Market Overview
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Laboratories
Other End Users

Cell Isolation Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGAA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard Biotools (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alfa Laval (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Signaling Technology, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micareo Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Applied Cells Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stemcell Technologies (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Bioarray (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proteintech Group, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Magbio Genomics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Akadeum Life Sciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pluriselect Life Science Ug (Haftungsbeschrankt) & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invent Biotechnologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments